aiqbench analysis
Utah's regulatory approval marks a significant policy shift allowing an AI system to autonomously issue prescription refills for acne treatments with minimal human oversight. This development highlights the evolving intersection of healthcare regulation and autonomous machine learning capabilities, setting a precedent for future AI-driven clinical decision-making.
Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments
Utah has become the first state in the U.S. to give an artificial intelligence startup permission to automate the approval of prescription refills with only minimal oversight from human physicians. In a blog post today, Nolla Health said it has been granted approval by the state to launch a pilot project that will enable acne […] The post Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments appeared first on SiliconANGLE.
Utah has become the first state in the U.S. to give an artificial intelligence startup permission to automate the approval of prescription refills with only minimal oversight from human physicians. In a blog post, Nolla Health said it has been granted approval by the state to launch a pilot project that will enable acne sufferers to talk to an AI agent, upload a photo of their face, and then automatically receive a prescription without speaking to a doctor. “This makes Nolla the first ever end-to-end AI doctor,” said Nolla Health founder Luis Wenus in a post on X…
Excerpt shown under the publisher's RSS terms · 98 words · full text and figures are on the publisher's site
Related coverage

This startup is issuing AI-generated acne prescriptions
The Verge · Oct 5, 2026

Digital States 2026: AI Moves From Experiment to Infrastructure
govtech.com · Sep 24, 2026

[AINews] Meta Muse Wonder & Wonder Full: MSL’s Claude 5.5-tier Frontier Model
Latent Space · Oct 13, 2026

New in Together GPU Clusters: Reliability and control for production GPU clusters
Together AI · Jul 15, 2026